|
COX7A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.857600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.802600E-01 |
| Normal-vs-Stage2 |
4.107800E-01 |
| Normal-vs-Stage3 |
2.007700E-04 |
| Normal-vs-Stage4 |
6.397300E-03 |
| Stage1-vs-Stage2 |
3.513600E-01 |
| Stage1-vs-Stage3 |
2.300400E-02 |
| Stage1-vs-Stage4 |
5.375900E-02 |
| Stage2-vs-Stage3 |
1.925420E-01 |
| Stage2-vs-Stage4 |
1.797030E-01 |
| Stage3-vs-Stage4 |
7.860200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.482400E-01 |
| Normal-vs-AfricanAmerican |
5.482000E-01 |
| Normal-vs-Asian |
4.652400E-01 |
| Caucasian-vs-AfricanAmerican |
2.531400E-01 |
| Caucasian-vs-Asian |
9.757000E-01 |
| AfricanAmerican-vs-Asian |
3.287800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.690200E-01 |
| Normal-vs-Female |
9.201800E-02 |
| Male-vs-Female |
5.353000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.565200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.584370E-01 |
| Normal-vs-Age(61-80Yrs) |
4.430200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.860200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.038000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.610000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.846400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.554800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.336600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.093200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.116300E-02 |
| Normal-vs-Grade 2 |
9.850200E-01 |
| Normal-vs-Grade 3 |
2.338400E-02 |
| Normal-vs-Grade 4 |
1.827550E-02 |
| Grade 1-vs-Grade 2 |
2.588600E-01 |
| Grade 1-vs-Grade 3 |
8.457800E-01 |
| Grade 1-vs-Grade 4 |
7.243600E-01 |
| Grade 2-vs-Grade 3 |
2.352600E-01 |
| Grade 2-vs-Grade 4 |
1.230220E-01 |
| Grade 3-vs-Grade 4 |
5.045400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.954590E-04 |
| Normal-vs-ccB subtype |
6.941800E-01 |
| ccA subtype-vs-ccB subtype |
5.039900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.566360E-01 |
| Normal-vs-N1 |
1.718800E-01 |
| N0-vs-N1 |
5.060000E-01 |
|
|
